Showing 403 results

Filters Content type: News, Editors' picks Topic: Changing treatment

A change of HIV treatment may be necessary because of side-effects, the development of drug resistance, treatment not being fully effective or because of interactions between HIV drugs and other medications.

Side effects

Switch From Efavirenz to Rilpivirine Quells CNS Toxicity, Improves Sleep

Editor's pick
NATAP
16 September 2014
Resistance

Longer time to virological failure and less drug resistance seen in people taking Atripla than in people taking separate drugs

News
9 September 2014
Changing treatment

Switching from first-line ART with suppressed viral load linked to treatment failure

News
29 July 2014
HIV treatment

Dolutegravir demonstrates good efficacy despite resistance

News
24 July 2014
New & experimental HIV treatments

Therapy with newer, safer antiretrovirals an option for the majority of HIV-positive patients

News
11 July 2014
Adherence

Switch from single-tablet regimen to 3 tablets works in Denmark

Editor's pick
International AIDS Society
10 July 2014
Treatment guidelines

New ARV prescribing guidelines for London (2014)

Editor's pick
HIV i-Base
1 July 2014
Changing treatment

People starting therapy on a boosted protease inhibitor don't need to switch after one virological failure episode, study indicates

News
9 June 2014
Changing treatment

Viral load rebounds in 35% of people using PI/r monotherapy: results of five-year PIVOT study

Editor's pick
HIV i-Base
10 March 2014
Treatment outcomes & life expectancy

Higher pill burden is associated with poorer adherence to HIV therapy and reduced chances of achieving an undetectable viral load

News
31 January 2014
Resistance

Successful HIV drug resistance testing is possible when viral load is low

News
27 January 2014
Changing treatment

U.S. FDA Approves Gilead’s Once-Daily Single Tablet HIV-1 Regimen Complera® for Patients Switching from a Stable Regimen

Editor's pick
Gilead press release
16 December 2013
Treatment guidelines

Systematic review and meta-analysis shows equivalence of 3TC and FTC

News
20 November 2013
New & experimental HIV treatments

Once-daily raltegravir effective as maintenance therapy

News
31 October 2013
Changing treatment

Once-daily raltegravir for 48 weeks as maintenance therapy in Paris

Editor's pick
NATAP
22 October 2013
Bone & joint problems

TDF/FTC-to-ABC/3TC switch maintains viral suppression, eases bone markers

Editor's pick
NATAP
19 September 2013
Changing treatment

Switching From Efavirenz to Rilpivirine Combo Quells CNS Side Effects

Editor's pick
NATAP
13 September 2013
Changing treatment

Lessons Learned When the Labs Go Awry

Editor's pick
TheBody.com
10 September 2013
Viral load

Persisently detectable viral load at any level increases risk of HIV treatment failure

News
29 August 2013
Kidney problems

Kidney problems linked to tenofovir use, improve with switch to abacavir

News
10 July 2013
Changing treatment

Study supports WHO recommendations for second-line HIV therapy in resource-limited countries

News
4 July 2013
Starting treatment

AZT associated with poorer immunological recovery in people taking first-line HIV treatment in southern Africa

News
22 May 2013
UK health services

London HIV drug prescribing changes – patient satisfaction and clinical outcomes maintained

News
22 April 2013
Resistance

Computer models predict how patients will respond to HIV drugs

Editor's pick
Eurekalert Inf Dis
14 March 2013